| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y601-01014 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101102485-B1 |
| titleOfInvention |
Novel Use of the JR Protein or Fragment thereof |
| abstract |
The present invention relates to an anticancer composition comprising a full-length GRS protein or fragment thereof, a nucleic acid encoding the GRS protein or fragment thereof as an active ingredient. Since the GRS protein or fragment thereof has a particularly excellent activity of inducing cancer cell death, the composition of the present invention containing the nucleic acid encoding the GRS protein or fragment thereof may be usefully used for anticancer.n n n n GRS, Protein, Anticancer, Composition |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015183018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101935372-B1 |
| priorityDate |
2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |